Ziprasidone
Internal
Analytical
Information
Ziprasidone, an atypical antipsychotic, is approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia, bipolar mania, and acute agitation in individuals with schizophrenia.
+719 535 8000 | Hours 7:30am-5:00pm | Colorado Springs, CO • Serving all U.S. states
Ziprasidone, an atypical antipsychotic, is approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia, bipolar mania, and acute agitation in individuals with schizophrenia.